Suchergebnisse - "Gasparin, Andrese Aline"

PubPharm (32)

1

Characterization of the patterns of care, access, and direct cost of systemic lupus erythematosus in Brazil : findings from the Macunaíma study

enthalten in: Advances in rheumatology (London, England) | 2024

von de Abreu, M. | Monticielo, O. | Fernandes, V. | +21

2

Characterization of the patterns of care, access, and direct cost of systemic lupus erythematosus in Brazil: findings from the Macunaíma study

enthalten in: Advances in rheumatology | 2024

von de Abreu, M. | Monticielo, O. | Fernandes, V. | +21

3

What is known about the effects of vitamin D in neuropsychiatric lupus?

enthalten in: Advances in rheumatology (London, England) | 2024

von Karnopp, T. | da Silva Freitas, V. | Di Domenico, A. | +5

4

Patients with longstanding pPatients with longstanding psoriatic arthritis can achieve DAPSA remission or low disease activity and it correlates to better functional outcomes : results from a Latin-American real-life cohort

enthalten in: Advances in rheumatology (London, England) | 2024

von Cruz, L. | Farani, J. | Costa, J. | +10

5

Patients with longstanding psoriatic arthritis can achieve DAPSA remission or low disease activity and it correlates to better functional outcomes: results from a Latin-American real-life cohort

enthalten in: Advances in rheumatology | 2024

von Cruz, L. | Farani, J. | Costa, J. | +10

6

What is known about the effects of vitamin D in neuropsychiatric lupus?

enthalten in: Advances in rheumatology | 2024

von Karnopp, T. | da Silva Freitas, V. | Di Domenico, A. | +5

7

Assessment of muscle mass using chest computed tomography-based quantitative and qualitative measurements in patients with systemic sclerosis : A retrospective study with cross-sectional and longitudinal analyses

enthalten in: Seminars in arthritis and rheumatism | 2023

von da Rocha, D. | Tessari, J. | Mainardi, N. | +6

8

Physical frailty in patients with systemic sclerosis

enthalten in: Seminars in arthritis and rheumatism | 2022

von Hax, V. | Tessari, J. | Pena, E. | +8

9

Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis

enthalten in: ResearchSquare.com | 2022

von Gasparin, A. | de Andrade, N. | Hax, V. | +6

10

Urinary soluble VCAM-1 is a useful biomarker of disease activity and treatment response in lupus nephritis

enthalten in: ResearchSquare.com | 2022

von Gasparin, A. | de Andrade, N. | Hax, V. | +6